AdvertisementMedicare proposes covering expensive Alzheimer's drug for those in clinical trialsJanuary 11, 2022Jonathan FranklinfacebookEmailThe Biogen Inc., headquarters is shown in Cambridge, Mass. Medicare says it will limit coverage of a $28,200-per-year Alzheimer's drug whose benefits have been questioned. (AP)
